Cargando…
A framework to guide dose & regimen strategy for clinical drug development
Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance of risks a...
Autores principales: | Sander, Oliver, Magnusson, Baldur, Ludwig, Inga, Jullion, Astrid, Meille, Christophe, Lorand, Daniel, Bornkamp, Björn, Hinder, Markus, Kovacs, Steven J., Looby, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592517/ https://www.ncbi.nlm.nih.gov/pubmed/34562310 http://dx.doi.org/10.1002/psp4.12701 |
Ejemplares similares
-
Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021) -
Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment
por: Wilbaux, Mélanie, et al.
Publicado: (2022) -
Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
por: Bauer, Sebastian, et al.
Publicado: (2021) -
Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance
por: Stein, Andrew M., et al.
Publicado: (2018) -
Stress and adolescent well-being: the need for an interdisciplinary framework
por: Sigfusdottir, Inga Dora, et al.
Publicado: (2017)